Differences
This shows you the differences between two versions of the page.
wiki:2.1.11.9.2.1_tricyclic_antidepressants [2019/02/19 15:50] – created - external edit 127.0.0.1 | wiki:2.1.11.9.2.1_tricyclic_antidepressants [2025/04/13 05:10] (current) – ↷ Links adapted because of a move operation 177.223.76.56 | ||
---|---|---|---|
Line 65: | Line 65: | ||
Less than 10 % of TCA circulates as free drug, the rest is bound to circulating proteins (albumin and alpha1 acid glycoprotein) or dissolved in circulating free fatty acids. Alpha1 acid glycoprotein (AAG) has high and low affinity binding sites for TCA. AAG is a more important binding protein than albumin, additional AAG can reverse TCA toxicity whereas albumin has no affect. The “bound” fraction is sensitive to changes in pH with acidosis causing an increase in free fraction. | Less than 10 % of TCA circulates as free drug, the rest is bound to circulating proteins (albumin and alpha1 acid glycoprotein) or dissolved in circulating free fatty acids. Alpha1 acid glycoprotein (AAG) has high and low affinity binding sites for TCA. AAG is a more important binding protein than albumin, additional AAG can reverse TCA toxicity whereas albumin has no affect. The “bound” fraction is sensitive to changes in pH with acidosis causing an increase in free fraction. | ||
- | [[:wikitox: | + | [[:concept_serum_alkalinization|Alkalinisation]] causes significant decrease in the percentage of free amitriptyline; |
==== Metabolism - Elimination ==== | ==== Metabolism - Elimination ==== | ||
Line 163: | Line 163: | ||
Most patients with significant ingestions of TCAs who are likely to have cardiac complications or seizures have a significantly impaired level of consciousness prior to those complications. Patients will often have a rapid onset of decreasing level of consciousness and coma because of a very rapid absorption of the drug. Patients should be assessed on admission to see if they are hyperreflexic or have myoclonic jerks or any evidence of seizure activity. Some patients who are likely to have seizures may be noted to have relatively brisk reflexes compared to the normal hyporeflexia seen with coma from other causes. This can be a marker of high seizure risk. | Most patients with significant ingestions of TCAs who are likely to have cardiac complications or seizures have a significantly impaired level of consciousness prior to those complications. Patients will often have a rapid onset of decreasing level of consciousness and coma because of a very rapid absorption of the drug. Patients should be assessed on admission to see if they are hyperreflexic or have myoclonic jerks or any evidence of seizure activity. Some patients who are likely to have seizures may be noted to have relatively brisk reflexes compared to the normal hyporeflexia seen with coma from other causes. This can be a marker of high seizure risk. | ||
- | Seizures themselves are associated with an increased mortality. Acidosis affects the [[:wikitox: | + | Seizures themselves are associated with an increased mortality. Acidosis affects the [[:concept_serum_alkalinization|partitioning of TCAs between the cell membrane and the Na+ channel binding site]] and increases TCA induced Na+ channel blockade. There may also be a small increase in free drug concentration from pH-mediated changes in protein binding but this is a less important effect. |
A number of TCAs (dothiepin, desipramine, | A number of TCAs (dothiepin, desipramine, | ||
Line 284: | Line 284: | ||
**Arrhythmias** \\ It is often very difficult to distinguish whether the patient is having a supraventricular arrhythmia with aberrant conduction or primary ventricular tachycardia. Most arrhythmias, | **Arrhythmias** \\ It is often very difficult to distinguish whether the patient is having a supraventricular arrhythmia with aberrant conduction or primary ventricular tachycardia. Most arrhythmias, | ||
- | Arrhythmias are best treated by correction of hypoxia and acidosis. This is achieved by administering oxygen and by [[:wikitox: | + | Arrhythmias are best treated by correction of hypoxia and acidosis. This is achieved by administering oxygen and by [[:concept_serum_alkalinization]] with bolus injections of intravenous sodium bicarbonate (1 to 2 meq of 8.4%). Further doses of sodium bicarbonate may be given cautiously depending on clinical response to achieve an arterial pH of 7.5-7.55 but care is needed to avoid a sustained alkalosis as pH>7.65 is potentially fatal. |
[[: | [[: | ||
- | **// | + | **// |
Treatment with plasma alkalinisation to a pH of 7.50 - 7.55 using sodium bicarbonate (to alter both pH and sodium) and/or hyperventilation is effective for all TCA induced arrhythmias. The initial treatment in critically ill patients is often titrated against clinical response with bolus injections of 1-3 mEq of sodium bicarbonate per kg body weight repeated at 3-5 minute intervals. When the clinical situation allows it, arterial blood pH should be checked. The target pH is 7.50 - 7.55, sustained elevations of pH greater than this are associated with impaired oxygen dissociation from hemoglobin. As the patient is usually ventilated the pH can be maintained with mild hyperventilation (pCO2 = 30 mmHg). | Treatment with plasma alkalinisation to a pH of 7.50 - 7.55 using sodium bicarbonate (to alter both pH and sodium) and/or hyperventilation is effective for all TCA induced arrhythmias. The initial treatment in critically ill patients is often titrated against clinical response with bolus injections of 1-3 mEq of sodium bicarbonate per kg body weight repeated at 3-5 minute intervals. When the clinical situation allows it, arterial blood pH should be checked. The target pH is 7.50 - 7.55, sustained elevations of pH greater than this are associated with impaired oxygen dissociation from hemoglobin. As the patient is usually ventilated the pH can be maintained with mild hyperventilation (pCO2 = 30 mmHg). |